Increased myeloid cell hypoxia-inducible factor-1 delays obliterative airway disease in the mouse

Activity of the HIF-pathway affects the development of allograft rejection, and our results suggest that myeloid cell-specific VHL-deficiency that potentially increases HIF-activity decreases allograft inflammation and the subsequent development of OAD in mouse tracheal allografts.